248 related articles for article (PubMed ID: 34418261)
1. Systemic lupus erythematosus after COVID-19 vaccination: A case report.
Patil S; Patil A
J Cosmet Dermatol; 2021 Oct; 20(10):3103-3104. PubMed ID: 34418261
[No Abstract] [Full Text] [Related]
2. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination.
Zavala-Miranda MF; González-Ibarra SG; Pérez-Arias AA; Uribe-Uribe NO; Mejia-Vilet JM
Kidney Int; 2021 Dec; 100(6):1340-1341. PubMed ID: 34560139
[No Abstract] [Full Text] [Related]
3. Letter to the editor regarding the article ''Patil S, Patil A. Systemic lupus erythematosus after COVID-19 vaccination: A case report. J Cosmet Dermatol. 2021 Aug 21. 10.1111/jocd.14386".
Abdullah L; Awada B; Kurban M; Abbas O
J Cosmet Dermatol; 2021 Dec; 20(12):4076-4077. PubMed ID: 34699662
[No Abstract] [Full Text] [Related]
4. Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
Barbhaiya M; Levine JM; Siegel CH; Bykerk VP; Jannat-Khah D; Mandl LA
Clin Rheumatol; 2022 May; 41(5):1619-1622. PubMed ID: 34716843
[No Abstract] [Full Text] [Related]
5. Clinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination.
Moriyama M; Noda K; Ito H; Matsushita T; Kurosaka D
Mod Rheumatol Case Rep; 2023 Dec; 8(1):63-68. PubMed ID: 37348045
[TBL] [Abstract][Full Text] [Related]
6. An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report.
Jin W; Tang Y; Wen C
Hum Vaccin Immunother; 2021 Nov; 17(11):4102-4104. PubMed ID: 34617875
[TBL] [Abstract][Full Text] [Related]
7. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.
Kreuter A; Burmann SN; Burkert B; Oellig F; Michalowitz AL
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e733-e735. PubMed ID: 34243220
[No Abstract] [Full Text] [Related]
8. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.
Ceccarelli F; Olivieri G; Natalucci F; Alessandri C; Conti F
Lupus; 2021 Sep; 30(10):1698-1699. PubMed ID: 34192958
[No Abstract] [Full Text] [Related]
10. The Use of COVID-19 Vaccines in Patients with SLE.
Tang W; Gartshteyn Y; Ricker E; Inzerillo S; Murray S; Khalili L; Askanase A
Curr Rheumatol Rep; 2021 Nov; 23(11):79. PubMed ID: 34767100
[TBL] [Abstract][Full Text] [Related]
11. Systemic Lupus Erythematosus and COVID-19.
Pappa M; Panagiotopoulos A; Thomas K; Fanouriakis A
Curr Rheumatol Rep; 2023 Oct; 25(10):192-203. PubMed ID: 37477841
[TBL] [Abstract][Full Text] [Related]
12. Lupus, vaccinations and COVID-19: What we know now.
Mason A; Anver H; Lwin M; Holroyd C; Faust SN; Edwards CJ
Lupus; 2021 Sep; 30(10):1541-1552. PubMed ID: 34134555
[TBL] [Abstract][Full Text] [Related]
13. The Emergence of new-onset SLE following SARS-CoV-2 vaccination.
Nune A; Iyengar KP; Ish P; Varupula B; Musat CA; Sapkota HR
QJM; 2021 Dec; 114(10):739-740. PubMed ID: 34450645
[No Abstract] [Full Text] [Related]
14. Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.
Joseph AK; Chong BF
Dermatol Ther; 2021 Nov; 34(6):e15114. PubMed ID: 34455671
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 vaccines in patients with SLE.
Tang W; Askanase AD; Khalili L; Merrill JT
Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33685998
[TBL] [Abstract][Full Text] [Related]
16. Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis.
Zengarini C; Pileri A; Salamone FP; Piraccini BM; Vitale G; La Placa M
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e179-e180. PubMed ID: 34807495
[No Abstract] [Full Text] [Related]
17. Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine.
Tuschen K; Bräsen JH; Schmitz J; Vischedyk M; Weidemann A
Kidney Int; 2021 Oct; 100(4):941-944. PubMed ID: 34352310
[No Abstract] [Full Text] [Related]
18. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus.
Ntouros PA; Vlachogiannis NI; Pappa M; Nezos A; Mavragani CP; Tektonidou MG; Souliotis VL; Sfikakis PP
Clin Immunol; 2021 Aug; 229():108765. PubMed ID: 34089859
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus myocarditis and COVID-19 vaccination: Comment.
Kleebayoon A; Wiwanitkit V
Reumatol Clin (Engl Ed); 2023; 19(6):349. PubMed ID: 37258399
[No Abstract] [Full Text] [Related]
20. Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli
Mathian A; Amoura Z
Ann Rheum Dis; 2021 Feb; 80(2):e26. PubMed ID: 32451345
[No Abstract] [Full Text] [Related]
[Next] [New Search]